Wednesday, June 9, 2010

FDA Guidance on Social Media

The increasing prevalence of social media into our everyday lives has not escaped pharma. However, "even though various business sectors have fervently embraced social media as a product marketing tool, FDA-regulated industries have been slow to adopt this practice" write Areta Kupchyk and Kevin Madagan. This is largely due to the absence of clear guidance from the regulatory agency on internet marketing activities including social media. For more information about the author's thoughts on the pending FDA guidance on social media, click here

No comments:

Post a Comment